[Seite 69↓]

Literaturverzeichnis

1 Adinoff,B.; Martin,P.R.; Bone,G.H.; Eckardt,M.J.; Roehrich,L.; George,D.T.; Moss,H.B.; Eskay,R.; Linnoila,M.; Gold,P.W.: Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence. Arch.Gen.Psychiatry. 1990, 47-4, S.325-330, PM:2157379.

2 Adinoff,B.; Risher-Flowers,D.; De Jong,J.; Ravitz,B.; Bone,G.H.; Nutt,D.J.; Roehrich,L.; Martin,P.R.; Linnoila,M.: Disturbances of hypothalamic-pituitary-adrenal axis functioning during ethanol withdrawal in six men. Am.J.Psychiatry. 1991, 148-8, S.1023-1025, PM:1853950.

3 Adinoff,B.; Ruether,K.; Krebaum,S.; Iranmanesh,A.; Williams,M.J.: Increased salivary cortisol concentrations during chronic alcohol intoxication in a naturalistic clinical sample of men. Alcohol Clin.Exp.Res.. 2003, 27-9, S.1420-1427, PM:14506402.

4 Aguirre,J.C.; del Arbol,J.L.; Raya,J.; Ruiz-Requena,M.E.; Rico,Irles J.: Plasma beta-endorphin levels in chronic alcoholics. Alcohol. 1990, 7-5, S.409-412, PM:2222843.

5 Aguirre,J.C.; del Arbol,J.L.; Rico,J.; Raya,J.; Miranda,M.T.: Classification of alcoholics on the basis of plasma beta-endorphin concentration. Alcohol. 1995, 12-6, S.531-534, PM:8590614.

6 Allemann,P.I.: Markers for excessive alcohol use (screening). Ther.Umsch.. 2000, 57-4, S.185-190, PM:10804874.

7 American Psychiatric Association: Diagnostic and statistical manual of mental disorders (4th edition) (DSM-IV). American Psychiatric Association, Committee on Nomenclature and Statistics. 1994, S.195-196,

8 Aubrun,F.; Bunge,D.; Langeron,O.; Saillant,G.; Coriat,P.; Riou,B.: Postoperative morphine consumption in the elderly patient. Anesthesiology. 2003, 99-1, S.160-165, PM:12826856.

9 Bacarese-Hamilton,T.; Cattini,R.; Shandley,C.; Howard,C.; Palmer,R.; McFarthing,K.: A fully automated enzyme immunoassay for the measurement of cortisol in biological fluids. Eur.J.Clin.Chem.Clin.Biochem.. 1992, 30-9, S.531-535, PM:1457615.

10 Bertagna,X.: Proopiomelanocortin-derived peptides. Endocrinol.Metab Clin.North Am.. 1994, 23-3, S.467-485, PM:7805649.


[Seite 70↓]

11 Blot,W.J.; McLaughlin,J.K.; Winn,D.M.; Austin,D.F.; Greenberg,R.S.; Preston-Martin,S.; Bernstein,L.; Schoenberg,J.B.; Stemhagen,A.: Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res.. 1988, 48-11, S.3282-3287, PM:3365707.

12 Blum,K.; Trachtenberg,M.C.: Alcoholism: scientific basis of a neuropsychogenetic disease. Int.J.Addict.. 1988, 23-8, S.781-796, PM:2906332.

1 3 Bone,R.C.; Balk,R.A.; Cerra,F.B.; Dellinger,R.P.; Fein,A.M.; Knaus,W.A.; Schein,R.M.; Sibbald,W.J.: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992, 101-6, S.1644-1655, PM:1303622.

14 Bornstein,S.R.; Chrousos,G.P.: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J.Clin.Endocrinol.Metab. 1999, 84-5, S.1729-1736, PM:10323408.

15 Bornstein,S.R.; Rutkowski,H.: The adrenal hormone metabolism in the immune/inflammatory reaction. Endocr.Res.. 2002, 28-4, S.719-728, PM:12530688.

16 Buckingham,J.C.: Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides. Neuroendocrinology. 1982, 35-2, S.111-116, PM:6290921.

17 Buckingham,J.C.; Cooper,T.A.: Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine. Neuroendocrinology. 1984, 38-5, S.411-417, PM:6328347.

18 Cahill,C.A.; Matthews,J.D.; Akil,H.: Human plasma beta-endorphin-like peptides: a rapid, high recovery extraction technique and validation of radioimmunoassay. J.Clin.Endocrinol.Metab. 1983, 56-5, S.992-997, PM:6300182.

19 Celis,R.; Torres,A.; Gatell,J.M.; Almela,M.; Rodriguez-Roisin,R.; Agusti-Vidal,A.: Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest. 1988, 93-2, S.318-324, PM:3338299.

20 Ceriati,F.; Tebala,G.D.; De Cosmo,G.; Saraceni,C.; Coco,C.; Bosco,F.; Mariani,L.; Ceriati,E.; Zumbo,A.: A prospective randomized clinical trial on pain control after major abdominal surgery. Chir Ital.. 2003, 55-4, S.481-489, PM:12938592.

21 Cook,R.T.: Alcohol abuse, alcoholism, and damage to the immune system-a review. Alcohol Clin.Exp.Res.. 1998, 22-9, S.1927-1942, PM:9884135.

22 Costa,A.; Bono,G.; Martignoni,E.; Merlo,P.; Sances,G.; Nappi,G.: An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics. Psychoneuroendocrinology. 1996, 21-3, S.263-275, PM:8817725.


[Seite 71↓]

23 Craven,D.E.; Kunches,L.M.; Kilinsky,V.; Lichtenberg,D.A.; Make,B.J.; McCabe,W.R.: Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am.Rev.Respir.Dis.. 1986, 133-5, S.792-796, PM:3706887.

24 Craven,D.E.; Kunches,L.M.; Lichtenberg,D.A.; Kollisch,N.R.; Barry,M.A.; Heeren,T.C.; McCabe,W.R.: Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch.Intern.Med.. 1988, 148-5, S.1161-1168, PM:3365084.

25 Dave,J.R.; Eiden,L.E.; Karanian,J.W.; Eskay,R.L.: Ethanol exposure decreases pituitary corticotropin-releasing factor binding, adenylate cyclase activity, proopiomelanocortin biosynthesis, and plasma beta-endorphin levels in the rat. Endocrinology. 1986, 118-1, S.280-286, PM:2934242.

26 del Arbol,J.L.; Aguirre,J.C.; Raya,J.; Rico,J.; Ruiz-Requena,M.E.; Miranda,M.T.: Plasma concentrations of beta-endorphin, adrenocorticotropic hormone, and cortisol in drinking and abstinent chronic alcoholics. Alcohol. 1995, 12-6, S.525-529, PM:8590613.

27 Delitala,G.; Trainer,P.J.; Oliva,O.; Fanciulli,G.; Grossman,A.B.: Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man. J.Endocrinol.. 1994, 141-1, S.163-168, PM:8031419.

28 Eggers,V.; Tio,J.; Neumann,T.; Pragst,F.; Muller,C.; Schmidt,L.G.; Kox,W.J.; Spies,C.D.: Blood alcohol concentration for monitoring ethanol treatment to prevent alcohol withdrawal in the intensive care unit. Intensive Care Med.. 2002, 28-10, S.1475-1482, PM:12373474.

29 Ehrenreich,H.; Kolmar,C.; Muller,O.A.; Goebel,F.D.: Potentiation of the hCRF-induced release of ACTH in man by an opioid antagonist. Klin.Wochenschr.. 1987, 65-10, S.453-457, PM:3037181.

30 Ehrenreich,H.; Schuck,J.; Stender,N.; Pilz,J.; Gefeller,O.; Schilling,L.; Poser,W.; Kaw,S.: Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcohol Clin.Exp.Res.. 1997, 21-7, S.1285-1293, PM:9347091.

31 Engelhardt,D.: Steroid biosynthesis inhibitors in Cushing's syndrome. Clin.Investig.. 1994, 72-7, S.481-488, PM:7981573.

32 Engelhardt,D.; Weber,M.M.: Therapy of Cushing's syndrome with steroid biosynthesis inhibitors. J.Steroid Biochem.Mol.Biol.. 1994, 49-4-6, S.261-267, PM:8043488.


[Seite 72↓]

33 Esel,E.; Sofuoglu,S.; Aslan,S.S.; Kula,M.; Yabanoglu,I.; Turan,M.T.: Plasma levels of beta-endorphin, adrenocorticotropic hormone and cortisol during early and late alcohol withdrawal. Alcohol Alcohol. 2001, 36-6, S.572-576, PM:11704624.

34 Ewing,J.A.: Detecting alcoholism. The CAGE questionnaire. JAMA. 1984, 252-14, S.1905-1907, PM:6471323.

35 Fassbender,K.; Pargger,H.; Muller,W.; Zimmerli,W.: Interleukin-6 and acute-phase protein concentrations in surgical intensive care unit patients: diagnostic signs in nosocomial infection. Crit Care Med.. 1993, 21-8, S.1175-1180, PM:8339583.

36 Garner,J.S.; Jarvis,W.R.; Emori,T.G.; Horan,T.C.; Hughes,J.M.: CDC definitions for nosocomial infections 1988. Z.Arztl.Fortbild.(Jena). 1991, 85-17, S.818-827, PM:1659046.

37Gianoulakis,C.: The effect of ethanol on the biosynthesis and regulation of opioid peptides. Experientia. 1989, 45-5, S.428-435, PM:2656284.

38 Gianoulakis,C.; Beliveau,D.; Angelogianni,P.; Meaney,M.; Thavundayil,J.; Tawar,V.; Dumas,M.: Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci.. 1989, 45-12, S.1097-1109, PM:2529410.

39Gianoulakis,C.; Krishnan,B.; Thavundayil,J.: Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism. Arch.Gen.Psychiatry. 1996, 53-3, S.250-257, PM:8611062.

40 Gianoulakis,C.; de Waele,J.P.; Thavundayil,J.: Implication of the endogenous opioid system in excessive ethanol consumption. Alcohol. 1996, 13-1, S.19-23, PM:8837929.

41 Gomez-Flores,R.; Weber,R.J.: Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray. Immunopharmacology. 2000, 48-2, S.145-156, PM:10936512.

42 Gronbaek,M.; Becker,U.; Johansen,D.; Tonnesen,H.; Jensen,G.; Sorensen,T.I.: Population based cohort study of the association between alcohol intake and cancer of the upper digestive tract. BMJ. 1998, 317-7162, S.844-847, PM:9748175.

43 Groote,Veldman R.; Meinders,A.E.: On the mechanism of alcohol-induced pseudo-Cushing's syndrome. Endocr.Rev.. 1996, 17-3, S.262-268, PM:8771359.

44 Grossman,A.: Brain opiates and neuroendocrine function. Clin.Endocrinol.Metab. 1983, 12-3, S.725-746, PM:6323067.


[Seite 73↓]

45 Hansbrough,J.F.; Zapata-Sirvent,R.L.; Carroll,W.J.; Johnson,R.; Saunders,C.E.; Barton,C.A.: Administration of intravenous alcohol for prevention of withdrawal in alcoholic burn patients. Am.J.Surg.. 1984, 148-2, S.266-269, PM:6465435.

46 Hasselbalch,H.; Selmer,J.; Sestoft,L.; Kehlet,H.: Hypothalamic-pituitary-adrenocortical function in chronic alcoholism. Clin.Endocrinol.(Oxf). 1982, 16-1, S.73-76, PM:7074973.

47 Heil,T.; Spies,C.; Bullmann,C.; Neumann,T.; Eyrich,K.; Muller,C.; Rommelspacher,H.: The relevance of CDT (carbohydrate-deficient transferrin). Preoperative diagnosis of chronic alcohol abuse in intensive care patients following elective tumor resection. Anaesthesist. 1994, 43-7, S.447-453, PM:8092454.

48 Heil,T.; Spies,C.D.; Hannemann,L.; Reinhart,K.; Eyrich,K.: Pharmakologische Ansätze zur Prophylaxe und Therapie des postoperativen Alkoholentzugssyndroms. Anesth.Intensivmed.. 1992, 33, S.33-37,

49 Helander,A.; Husa,A.; Jeppsson,J.O.: Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin.Chem.. 2003, 49-11, S.1881-1890, PM:14578320.

50 Heuser,I.; von Bardeleben,U.; Boll,E.; Holsboer,F.: Response of ACTH and cortisol to human corticotropin-releasing hormone after short-term abstention from alcohol abuse. Biol.Psychiatry. 1988, 24-3, S.316-321, PM:2840977.

51 Holsboer,F.; Spengler,D.; Heuser,I.: The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog.Brain Res.. 1992, 93, S.385-417, PM:1336204.

52 Homann,N.: Alcohol and cancer. Ther.Umsch.. 2000, 57-4, S.236-240, PM:10804883.

53 Houghtling,R.A.; Mellon,R.D.; Tan,R.J.; Bayer,B.M.: Acute effects of morphine on blood lymphocyte proliferation and plasma IL-6 levels. Ann.N.Y.Acad.Sci.. 2000, 917, S.771-777, PM:11268406.

5 4 Hundt,W.; Zimmermann,U.; Pottig,M.; Spring,K.; Holsboer,F.: The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal. Alcohol Clin.Exp.Res.. 2001, 25-5, S.687-691, PM:11371718.

55 Inder,W.J.; Joyce,P.R.; Ellis,M.J.; Evans,M.J.; Livesey,J.H.; Donald,R.A.: The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides. Clin.Endocrinol.(Oxf). 1995, 43-3, S.283-290, PM:7586596.

5 6 Iranmanesh,A.; Lizarralde,G.; Johnson,M.L.; Veldhuis,J.D.: Circadian, ultradian, and episodic release of beta-endorphin in men, and its temporal coupling with cortisol. J.Clin.Endocrinol.Metab. 1989, 68-6, S.1019-1026, PM:2524500.


[Seite 74↓]

57 Iranmanesh,A.; Veldhuis,J.D.; Johnson,M.L.; Lizarralde,G.: 24-hour pulsatile and circadian patterns of cortisol secretion in alcoholic men. J.Androl. 1989, 10-1, S.54-63, PM:2708124.

5 8 Jeffcoate,W.: Alcohol-induced pseudo-Cushing's syndrome. Lancet. 1993, 341-8846, S.676-677, PM:8095582.

59 Jensen,N.H.; Dragsted,L.; Christensen,J.K.; Jorgensen,J.C.; Qvist,J.: Severity of illness and outcome of treatment in alcoholic patients in the intensive care unit. Intensive Care Med.. 1988, 15-1, S.19-22, PM:3230195.

60 Jessop,D.S.: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. J.Endocrinol.. 1999, 160-2, S.169-180, PM:9924185.

61 Jessop,D.S.: Stimulatory and inhibitory regulators of the hypothalamo-pituitary-adrenocortical axis. Baillieres Best.Pract.Res.Clin.Endocrinol.Metab. 1999, 13-4, S.491-501, PM:10903810.

62 Kiefer,F.; Horntrich,M.; Jahn,H.; Wiedemann,K.: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency?. Psychopharmacology (Berl) . 2002, 162-4, S.433-437, PM:12172698.

63 Kikuchi,K.; Tanaka,M.; Abe,K.; Yamaguchi,K.; Kimura,S.; Adachi,I.: Rapid and specific radioimmunoassays for beta-endorphin and beta-lipotropin in affinity-purified human plasma. J.Clin.Endocrinol.Metab. 1984, 59-2, S.287-292, PM:6330153.

64 Kirkman,S.; Nelson,D.H.: Alcohol-induced pseudo-Cushing's disease: a study of prevalence with review of the literature. Metabolism. 1988, 37-4, S.390-394, PM:2833680.

65 Knaus,W.A.; Wagner,D.P.; Draper,E.A.; Zimmerman,J.E.; Bergner,M.; Bastos,P.G.; Sirio,C.A.; Murphy,D.J.; Lotring,T.; Damiano,A.; .: The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991, 100-6, S.1619-1636, PM:1959406.

66 Kobayashi,Y.; Tsubota,N.; Miyai,K.; Watanabe,F.: Fluorescence quenching immunoassay of serum cortisol. Steroids. 1980, 36-2, S.177-183, PM:7444988.

67 Lee,S.; Rivier,C.: Long-term influence of an initial exposure to alcohol on the rat hypothalamic-pituitary axis. Alcohol Clin.Exp.Res.. 2003, 27-9, S.1463-1470, PM:14506408.

68 Lieber,C.S.: Medical disorders of alcoholism. N.Engl.J.Med.. 1995, 333-16, S.1058-1065, PM:7675050.


[Seite 75↓]

69 Lingen,M.; Sturgis,E.M.; Kies,M.S.: Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biologic characteristics and implications for management. Curr.Opin.Oncol.. 2001, 13-3, S.176-182, PM:11307061.

70 MacGregor,R.R.; Louria,D.B.: Alcohol and infection. Curr.Clin.Top.Infect.Dis.. 1997, 17, S.291-315, PM:9189671.

71 Malangoni,M.A.; Crafton,R.; Mocek,F.C.: Pneumonia in the surgical intensive care unit: factors determining successful outcome. Am.J.Surg.. 1994, 167-2, S.250-255, PM:8135314.

72 Marchesi,C.; Chiodera,P.; Ampollini,P.; Volpi,R.; Coiro,V.: Beta-endorphin, adrenocorticotropic hormone and cortisol secretion in abstinent alcoholics. Psychiatry Res.. 1997, 72-3, S.187-194, PM:9406908.

73 Marx,C.; Ehrhart-Bornstein,M.; Scherbaum,W.A.; Bornstein,S.R.: Regulation of adrenocortical function by cytokines--relevance for immune-endocrine interaction. Horm.Metab Res.. 1998, 30-6-7, S.416-420, PM:9694572.

74 McDonald,R.K.; Evans,F.T.; Weise,V.K.; Patrick,R.W.: Effect of morphine and nalorphine on plasma hydrocortisone levels in man. J.Pharmacol.Exp.Ther.. 1959, 125-3, S.241-247, PM:13642265.

75 Mendenhall,C.L.; Theus,S.A.; Roselle,G.A.; Grossman,C.J.; Rouster,S.D.: Biphasic in vivo immune function after low- versus high-dose alcohol consumption. Alcohol. 1997, 14-3, S.255-260, PM:9160803.

76 Merry,J.; Marks,V.: The effects of alcohol, barbiturate, and diazepam on hypothalamic-pituitary-adrenal function in chronic alcoholics. Lancet. 1972, 2-7785, S.990-991, PM:4116981.

77 Miller,J.W.; Crapo,L.: The medical treatment of Cushing's syndrome. Endocr.Rev.. 1993, 14-4, S.443-458, PM:7693447.

78 Moore,R.D.; Bone,L.R.; Geller,G.; Mamon,J.A.; Stokes,E.J.; Levine,D.M.: Prevalence, detection, and treatment of alcoholism in hospitalized patients. JAMA. 1989, 261-3, S.403-407, PM:2909780.

79 Morgan,M.Y.: Alcohol and the endocrine system. Br.Med.Bull.. 1982, 38-1, S.35-42, PM:7046871.

80 Morita,M.; Saeki,H.; Mori,M.; Kuwano,H.; Sugimachi,K.: Risk factors for esophageal cancer and the multiple occurrence of carcinoma in the upper aerodigestive tract. Surgery . 2002, 131-1 Suppl, S.S1-S6, PM:11821780.


[Seite 76↓]

81 Mortimer,R.H.; Cannell,G.R.; Thew,C.M.; Galligan,J.P.: Ketoconazole and plasma and urine steroid levels in Cushing's disease. Clin.Exp.Pharmacol.Physiol. 1991, 18-8, S.563-569, PM:1655322.

82 Mulla,A.; Buckingham,J.C.: Regulation of the hypothalamo-pituitary-adrenal axis by cytokines. Baillieres Best.Pract.Res.Clin.Endocrinol.Metab. 1999, 13-4, S.503-521, PM:10903811.

83 Munson,P.L.: Effects of morphine and related drugs on the corticotrophin (ACTH)-stress reaction. Prog.Brain Res.. 1973, 39, S.361-372, PM:4363913.

84 Myers,R.D.; Melchior,C.L.: Alcohol drinking: abnormal intake caused by tetrahydropapaveroline in brain. Science. 1977, 196-4289, S.554-556, PM:557839.

85 Myers,R.D.; Critcher,E.C.: Naloxone alters alcohol drinking induced in the rat by tetrahydropapaveroline (THP) infused ICV. Pharmacol.Biochem.Behav.. 1982, 16-5, S.827-836, PM:6283568.

86 Napolitano,L.M.; Koruda,M.J.; Zimmerman,K.; McCowan,K.; Chang,J.; Meyer,A.A.: Chronic ethanol intake and burn injury: evidence for synergistic alteration in gut and immune integrity. J.Trauma. 1995, 38-2, S.198-207, PM:7869435.

87 Neumann,T.; Spies,C.D.: Use of biomarkers for alcohol use disorders in clinical practice. Addiction. 2003, 98, S.S2,

88 Nieman,L.K.: Medical therapy of Cushing's disease. Pituitary.. 2002, 5-2, S.77-82, PM:12675504.

89 Pilz,G.; Werdan,K.: Scores for multiple organ dysfunction and multiple organ failure. Internist (Berl). 1998, 39-5, S.502-508, PM:9647985.

90 Raff,H.; Shaker,J.L.; Nelson,D.K.; Findling,J.W.: Rapid measurement of corticotropin (ACTH) with a modified immunochemiluminescent assay. Clin.Chem.. 1994, 40-7, S.1344, PM:8013111.

91 Rantala,A.; Lehtonen,O.P.; Niinikoski,J.: Alcohol abuse: a risk factor for surgical wound infections?. Am.J.Infect.Control. 1997, 25-5, S.381-386, PM:9343620.

92 Rasmussen,D.D.; Boldt,B.M.; Bryant,C.A.; Mitton,D.R.; Larsen,S.A.; Wilkinson,C.W.: Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. Alcohol Clin.Exp.Res.. 2000, 24-12, S.1836-1849, PM:11141043.

93 Rees,L.H.; Besser,G.M.; Jeffcoate,W.J.; Goldie,D.J.; Marks,V.: Alcohol-induced pseudo-Cushing's syndrome. Lancet. 1977, 1-8014, S.726-728, PM:66521.

94 Ringborg,U.: Alcohol and risk of cancer. Alcohol Clin.Exp.Res.. 1998, 22-7 Suppl, S.323S-328S, PM:9799956.


[Seite 77↓]

95 Rittmaster,R.S.; Cutler,G.B.,Jr.; Sobel,D.O.; Goldstein,D.S.; Koppelman,M.C.; Loriaux,D.L.; Chrousos,G.P.: Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects. J.Clin.Endocrinol.Metab. 1985, 60-5, S.891-895, PM:2984235.

96 Rivier,C.; Bruhn,T.; Vale,W.: Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). J.Pharmacol.Exp.Ther.. 1984, 229-1, S.127-131, PM:6323684.

97 Rivier,C.; Vale,W.: Interaction between ethanol and stress on ACTH and beta-endorphin secretion. Alcohol Clin.Exp.Res.. 1988, 12-2, S.206-210, PM:2837103.

98 Rivier,C.: Alcohol stimulates ACTH secretion in the rat: mechanisms of action and interactions with other stimuli. Alcohol Clin.Exp.Res.. 1996, 20-2, S.240-254, PM:8730214.

99 Rivier,C.L.; Grigoriadis,D.E.; Rivier,J.E.: Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors. Endocrinology. 2003, 144-6, S.2396-2403, PM:12746300.

100 Rodriguez,J.L.; Gibbons,K.J.; Bitzer,L.G.; Dechert,R.E.; Steinberg,S.M.; Flint,L.M.: Pneumonia: incidence, risk factors, and outcome in injured patients. J.Trauma. 1991, 31-7, S.907-912, PM:2072428.

10 1 Rosenberger,P.; Muhlbauer,E.; Weissmuller,T.; Rommelspacher,H.; Sinha,P.; Wernecke,K.D.; Finckh,U.; Rettig,J.; Kox,W.J.; Spies,C.D.: Decreased proopiomelanocortin mRNA in lymphocytes of chronic alcoholics after intravenous human corticotropin releasing factor injection. Alcohol Clin.Exp.Res.. 2003, 27-11, S.1693-1700, PM:14634483.

102 Roth-Isigkeit,A.; Dibbelt,L.; Schmucker,P.; Seyfarth,M.: The immune-endocrine interaction varies with the duration of the inflammatory process in cardiac surgery patients. J.Neuroendocrinol.. 2000, 12-6, S.546-552, PM:10844583.

103 Roth-Isigkeit,A.K.; Schmucker,P.: Postoperative dissociation of blood levels of cortisol and adrenocorticotropin after coronary artery bypass grafting surgery. Steroids. 1997, 62-11, S.695-699, PM:9366007.

104 Roth-Isigkeit,A.K.; Dibbelt,L.; Schmucker,P.: Blood levels of corticosteroid-binding globulin, total cortisol and unbound cortisol in patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass. Steroids. 2000, 65-9, S.513-520, PM:10978730.


[Seite 78↓]

105 Ruckert,R.I.; Hoffmann,Y.; Rohde,W.: Some methodic aspects in optimizing the radioimmunoassay of beta-endorphin. Exp.Clin.Endocrinol.. 1986, 87-3, S.277-287, PM:2946595.

106 Saitz,R.; Ghali,W.A.; Moskowitz,M.A.: The impact of alcohol-related diagnoses on pneumonia outcomes. Arch.Intern.Med.. 1997, 157-13, S.1446-1452, PM:9224223.

107 Sander,M.; Irwin,M.; Sinha,P.; Naumann,E.; Kox,W.J.; Spies,C.D.: Suppression of interleukin-6 to interleukin-10 ratio in chronic alcoholics: association with postoperative infections. Intensive Care Med.. 2002, 28-3, S.285-292, PM:11904657.

108 Schafer,M.; Mousa,S.A.; Stein,C.: Corticotropin-releasing factor in antinociception and inflammation. Eur.J.Pharmacol.. 1997, 323-1, S.1-10, PM:9105870.

109 Schein,R.M.; Sprung,C.L.; Marcial,E.; Napolitano,L.; Chernow,B.: Plasma cortisol levels in patients with septic shock. Crit Care Med.. 1990, 18-3, S.259-263, PM:2302948.

110 Schroeder,S.; Wichers,M.; Klingmuller,D.; Hofer,M.; Lehmann,L.E.; von Spiegel,T.; Hering,R.; Putensen,C.; Hoeft,A.; Stuber,F.: The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone. Crit Care Med.. 2001, 29-2, S.310-316, PM:11246311.

111 Seitz,H.K.; Simanowski,U.A.: Ethanol and carcinogenesis of the alimentary tract. Alcohol Clin.Exp.Res.. 1986, 10-6 Suppl, S.33S-40S, PM:3544928.

11 2 Seitz,H.K.; Poschl,G.; Simanowski,U.A.: Alcohol and cancer. Recent Dev.Alcohol. 1998, 14, S.67-95, PM:9751943.

113 Sonino,N.; Boscaro,M.; Paoletta,A.; Mantero,F.; Ziliotto,D.: Ketoconazole treatment in Cushing's syndrome: experience in 34 patients. Clin.Endocrinol.(Oxf). 1991, 35-4, S.347-352, PM:1752063.

114 Spencer,R.L.; McEwen,B.S.: Adaptation of the hypothalamic-pituitary-adrenal axis to chronic ethanol stress. Neuroendocrinology. 1990, 52-5, S.481-489, PM:2126355.

115 Spies,C.: Anesthesiologic aspects of chronic alcohol abuse. Ther.Umsch.. 2000, 57-4, S.261-63, PM:10804888.

116 Spies,C.; Tonnesen,H.; Andreasson,S.; Helander,A.; Conigrave,K.: Perioperative morbidity and mortality in chronic alcoholic patients. Alcohol Clin.Exp.Res.. 2001, 25-5 Suppl, S.164S-170S, PM:11391067.


[Seite 79↓]

117 Spies,C.D.; Rommelspacher,H.; Schnapper,C.; Muller,C.; Marks,C.; Berger,G.; Conrad,C.; Blum,S.; Specht,M.; Hannemann,L.; .: Beta-carbolines in chronic alcoholics undergoing elective tumor resection. Alcohol Clin.Exp.Res.. 1995, 19-4, S.969-976, PM:7485848.

118 Spies,C.D.; Dubisz,N.; Funk,W.; Blum,S.; Muller,C.; Rommelspacher,H.; Brummer,G.; Specht,M.; Hannemann,L.; Striebel,H.W.; .: Prophylaxis of alcohol withdrawal syndrome in alcohol-dependent patients admitted to the intensive care unit after tumour resection. Br.J.Anaesth.. 1995, 75-6, S.734-739, PM:8672322.

119 Spies,C.D.; Nordmann,A.; Brummer,G.; Marks,C.; Conrad,C.; Berger,G.; Runkel,N.; Neumann,T.; Muller,C.; Rommelspacher,H.; Specht,M.; Hannemann,L.; Striebel,H.W.; Schaffartzik,W.: Intensive care unit stay is prolonged in chronic alcoholic men following tumor resection of the upper digestive tract. Acta Anaesthesiol.Scand.. 1996, 40-6, S.649-656, PM:8836256.

120 Spies,C.D.; Neuner,B.; Neumann,T.; Blum,S.; Muller,C.; Rommelspacher,H.; Rieger,A.; Sanft,C.; Specht,M.; Hannemann,L.; Striebel,H.W.; Schaffartzik,W.: Intercurrent complications in chronic alcoholic men admitted to the intensive care unit following trauma. Intensive Care Med.. 1996, 22-4, S.286-293, PM:8708164.

121 Spies,C.D.; Dubisz,N.; Neumann,T.; Blum,S.; Muller,C.; Rommelspacher,H.; Brummer,G.; Specht,M.; Sanft,C.; Hannemann,L.; Striebel,H.W.; Schaffartzik,W.: Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of a prospective, randomized trial. Crit Care Med.. 1996, 24-3, S.414-422, PM:8625628.

122 Spies,C.D.; Rommelspacher,H.: Alcohol withdrawal in the surgical patient: prevention and treatment. Anesth.Analg.. 1999, 88-4, S.946-954, PM:10195555.

123 Spies,CD; von Dossw,V.; Eggers,V.; Jetschmann,G.; El-Hilali,R.; Egert,J.; Fischer,M.; Schröder,T.; Höflich,C.; Sinha,P.; Paschen,C.; Mirsalim,P.; Brunsch,R.; Hopf,J.; Marks,C.; Wernecke,KD.; Pragst,F.; Ehrenreich,H.; Müller,C.; Tonnesen,H.; Oelkers,W.; Rohde,W.; Stein,C.; Kox,WJ.: Altered cell-mediated immunity and increased postoperative infection rate in chronic alcoholic patients. Anesthesiology. 2004,

124 Suemaru,S.; Hashimoto,K.; Ota,Z.: Effects of morphine on hypothalamic corticotropin-releasing factor (CRF), norepinephrine and dopamine in non-stressed and stressed rats. Acta Med.Okayama. 1985, 39-6, S.463-470, PM:3004111.

125 Suemaru,S.; Hashimoto,K.; Ota,Z.: Effect of morphine on hypothalamic corticotropin-releasing factor (CRF) and pituitary-adrenocortical activity. Endocrinol.Jpn.. 1986, 33-4, S.441-448, PM:3024953.


[Seite 80↓]

126 Suemaru,S.; Dallman,M.F.; Darlington,D.N.; Cascio,C.S.; Shinsako,J.: Role of alpha- adrenergic mechanism in effects of morphine on the hypothalamo-pituitary-adrenocortical and cardiovascular systems in the rat. Neuroendocrinology. 1989, 49-2, S.181-190, PM:2542829.

127 Sullivan,J.T.; Sykora,K.; Schneiderman,J.; Naranjo,C.A.; Sellers,E.M.: Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br.J.Addict.. 1989, 84-11, S.1353-1357, PM:2597811.

128 Szabo,G.: Consequences of alcohol consumption on host defence. Alcohol Alcohol. 1999, 34-6, S.830-841, PM:10659718.

129 Szabo,J.; Bruckner,G.; Medveczky,I.; Kosa,E.; Balogh,A.: Ethanol's effect on rat pituitary adrenal axis is prevented by purine metabolic pathway inhibitors. Proc.Soc.Exp.Biol.Med.. 1999, 220-2, S.112-118, PM:9933506.

130 Talbot,J.A.; Kane,J.W.; White,A.: Analytical and clinical aspects of adrenocorticotrophin determination. Ann.Clin.Biochem.. 2003, 40-5, S.453-471, PM:14503983.

131 Terzolo,M.; Panarelli,M.; Piovesan,A.; Torta,M.; Paccotti,P.; Angeli,A.: Ketoconazole treatment in Cushing's disease. Effect on the circadian profile of plasma ACTH and cortisol. J.Endocrinol.Invest. 1988, 11-10, S.717-721, PM:2852693.

13 2 Tonnesen,H.; Petersen,K.R.; Hojgaard,L.; Stokholm,K.H.; Nielsen,H.J.; Knigge,U.; Kehlet,H.: Postoperative morbidity among symptom-free alcohol misusers. Lancet. 1992, 340-8815, S.334-337, PM:1353805.

133 Tonnesen,H.; Kaiser,A.H.; Nielsen,B.B.; Pedersen,A.E.: Reversibility of alcohol-induced immune depression. Br.J.Addict.. 1992, 87-7, S.1025-1028, PM:1643394.

134 Tonnesen,H.: Influence of alcohol on several physiological functions and its reversibility: a surgical view. Acta Psychiatr.Scand.Suppl. 1992, 369, S.67-71, PM:1471555.

135 Tonnesen,H.: The alcohol patient and surgery. Alcohol Alcohol. 1999, 34-2, S.148-152, PM:10344774.

136 Tonnesen,H.; Rosenberg,J.; Nielsen,H.J.; Rasmussen,V.; Hauge,C.; Pedersen,I.K.; Kehlet,H.: Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. BMJ. 1999, 318-7194, S.1311-1316, PM:10323814.

137 Tonnesen,H.; Kehlet,H.: Preoperative alcoholism and postoperative morbidity. Br.J.Surg.. 1999, 86-7, S.869-874, PM:10417555.

138 Tsueda,K.; Loyd,G.E.; Heine,M.F.; Duque,F.; Haas,J.E.; Stocking,J.E.: Opiates in ethanol withdrawal. Anesth.Analg.. 1995, 81-4, S.874-877, PM:7574028.


[Seite 81↓]

139 van Nieuwenhoven,E.J.; Lefering,R.; Neugebauer,E.; Goris,R.J.: Clinical relevance of sepsis scores. Langenbecks Arch.Surg.. 1998, 383-1, S.11-14, PM:9627166.

140 von Bardeleben,U.; Heuser,I.; Holsboer,F.: Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse. Psychoneuroendocrinology. 1989, 14-6, S.441-449, PM:2560222.

141 von Heymann,C.; Langenkamp,J.; Dubisz,N.; von,Dossow,V; Schaffartzik,W.; Kern,H.; Kox,W.J.; Spies,C.: Posttraumatic immune modulation in chronic alcoholics is associated with multiple organ dysfunction syndrome. J.Trauma. 2002, 52-1, S.95-103, PM:11791058.

142 Wand,G.S.; Dobs,A.S.: Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. J.Clin.Endocrinol.Metab. 1991, 72-6, S.1290-1295, Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics.

143 Wardlaw,S.L.; Frantz,A.G.: Measurement of beta-endorphin in human plasma. J.Clin.Endocrinol.Metab . 1979, 48-1, S.176-180, PM:84817.

144 Williams,K.L.; Ko,M.C.; Rice,K.C.; Woods,J.H.: Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys. Psychoneuroendocrinology. 2003, 28-4, S.513-528, PM:12689609.

145 Yamaguchi,H.; Liotta,A.S.; Krieger,D.T.: Simultaneous determination of human plasma immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin using immuno-affinity chromatography. J.Clin.Endocrinol.Metab. 1980, 51-5, S.1002-1008, PM:6252227.

146Young,D.S.: Implementation of SI units for clinical laboratory data. Style specifications and conversion tables. Ann.Intern.Med.. 1987, 106-1, S.114-129, PM:3789557.

147 Zhou,Y.; Spangler,R.; Maggos,C.E.; Wang,X.M.; Han,J.S.; Ho,A.; Kreek,M.J.: Hypothalamic-pituitary-adrenal activity and pro-opiomelanocortin mRNA levels in the hypothalamus and pituitary of the rat are differentially modulated by acute intermittent morphine with or without water restriction stress. J.Endocrinol.. 1999, 163-2, S.261-267, PM:10556776.

148 Zimmermann,U.; Hundt,W.; Spring,K.; Grabner,A.; Holsboer,F.: Hypothalamic-pituitary-adrenal system adaptation to detoxification in alcohol-dependent patients is affected by family history of alcoholism. Biol.Psychiatry. 2003, 53-1, S.75-84, PM:12513947.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
17.05.2005